Skip to main content

Intelligent Asthma Monitoring Devices Market to Surpass 1696.7 Million by 2030 Drives Due to Increasing Prevalence of Asthma

SkyQuest projects that the intelligent asthma monitoring devices market will attain a value of USD 1696.7 million by 2030, with a CAGR of 25.1% over the forecast period (2023-2030). The rise in asthma cases has led to a surge in demand for cost-effective treatment options. However, one of the challenges faced by the market is the proper handling of devices and products, which can hinder intelligent asthma monitoring devices market growth.

Westford, USA, Aug. 24, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the increasing global prevalence of asthma is a crucial driver for the growing demand for intelligent asthma monitoring devices market. According to the World Health Organization, approximately 235 million people worldwide are affected by asthma, and this number is projected to rise further. This escalating prevalence underscores the need to monitor and manage the condition effectively.

Browse in-depth TOC on “Intelligent Asthma Monitoring Devices Market”

  • Pages – 157
  • Tables – 66
  • Figures – 75

Asthma is a medical condition characterized by the narrowing and inflammation of the airways, leading to difficulty breathing and triggering coughing episodes. The condition can also cause the production of excess mucus, further obstructing the airways. Individuals with asthma may experience wheezing, a high-pitched whistling sound during exhalation, and shortness of breath in the intelligent asthma monitoring devices market.

Get a sample copy of this report:

https://www.skyquestt.com/sample-request/intelligent-asthma-monitoring-devices-market

Prominent Players in Intelligent Asthma Monitoring Devices Market

  • Adherium Limited
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Cohero Health, Inc.
  • GlaxoSmithKline plc
  • Health Care Originals, Inc.
  • Inspiron Medical Ltd.
  • Ivivi Health Sciences LLC
  • Koko Health, Inc.
  • Medical International Research USA, Inc.
  • NuvoAir AB
  • Pneuma Respiratory, Inc.
  • Propeller Health
  • ResMed
  • Sensirion AG
  • Teva Pharmaceuticals Industries Ltd.
  • Thorasys Thoracic Medical Systems Inc.
  • Vitalograph Ltd.
  • Volansys Technologies Pvt. Ltd.
  • Zephyr Sleep Technologies

Smart Inhaler Segment is Expected to Grow the Market Due to the Increasing Acceptance and Adoption of Smart Inhalers

Smart inhaler segment is anticipated to hold a significant market share and exhibit the highest growth rate in the intelligent asthma monitoring devices market during the forecast period. This dominance can be attributed to the increasing acceptance and adoption of smart inhalers among healthcare providers and patients.

The markets in North America are anticipated to hold the largest share in the global intelligent asthma monitoring devices market during the forecast period. This significant market share can be attributed to several factors, including the growing awareness among individuals about the importance of asthma management and the increasing prevalence of allergic reactions in the region.

Browse summary of the report and Complete Table of Contents (ToC):

https://www.skyquestt.com/report/intelligent-asthma-monitoring-devices-market

Home Use Segment is Expected to Dominate the Market Due to Increasing Availability of Phone-Based Applications

Home use segment is projected to experience the fastest growth rate in the intelligent asthma monitoring devices market during the forecast period. This growth can be attributed to several factors, including the increasing availability of phone-based applications and the convenience of handling smart inhalers at home.

Regional markets in Europe are projected to be the second-leading intelligent asthma monitoring devices market, with substantial sales during the forecast period. However, the region’s sluggish economy may challenge the market growth. Economic factors such as reduced consumer spending, uncertainty, and financial constraints can impact the adoption and purchasing power of individuals seeking intelligent asthma monitoring devices.

A comprehensive analysis of the major players in the intelligent asthma monitoring devices market has been recently conducted in a report. The report encompasses various aspects, including collaborations, mergers, innovative business policies, and strategies, providing valuable insights into key trends and breakthroughs in the market. Furthermore, the report scrutinizes the market share of the top segments and presents a detailed geographic analysis. Lastly, the report highlights the major players in the industry and their endeavours to develop innovative solutions to cater to the growing demand.

Key Developments in Intelligent Asthma Monitoring Devices Market

  • Recently, Aparta Pharma made an announcement regarding the introduction of HeroTracker Sense. The launch of this product signifies a significant development in the intelligent asthma monitoring devices market. HeroTracker Sense is expected to offer advanced features and functionalities to enhance asthma management and monitoring.
  • Adherium Limited, a prominent player in the market, achieved FDA 510k approval for its innovative Hailie Sensor recently. This state-of-the-art device incorporates psychological measures to track asthma and chronic obstructive pulmonary disease (COPD) medications.

Speak to Analyst for your custom requirements:

https://www.skyquestt.com/speak-with-analyst/intelligent-asthma-monitoring-devices-market

 Key Questions Answered in Intelligent Asthma Monitoring Devices Market Report

  • What specific growth drivers are projected to impact the market during the forecast period?
  • List the top companies in the market and explain how they have achieved their positions of influence.
  • In what ways do regional trends and patterns differ within the global market, and how these differences shape the market’s future growth?

Related Reports in SkyQuest’s Library:

Global Neonatal Ventilators Market

Global Drug Delivery Market

Global Parenteral Nutrition Market

Global Pharmaceutical Analytical Testing Outsourcing Market

North America Mosquito Repellent Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: sales@skyquestt.com

LinkedIn Facebook Twitter

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.